GRAIL to Present at the Goldman Sachs 47th Annual Global Healthcare Conference
GRAIL (Nasdaq: GRAL) announced that management will present at the Goldman Sachs 47th Annual Global Healthcare Conference in Miami, FL on Tuesday, June 9 at 11:20 a.m. ET.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
GRAIL (Nasdaq: GRAL) announced that management will present at the Goldman Sachs 47th Annual Global Healthcare Conference in Miami, FL on Tuesday, June 9 at 11:20 a.m. ET.
Live and replay webcasts will be available in the investor relations section of GRAIL's website for at least 30 days.
Details
News Market Reaction – GRAL
On May 27, the first trading day after this news, GRAL closed 3.57% above the previous close.
Data tracked by StockTitan Argus for the May 27 session.
Key Figures
- Conference edition
- 47th
- Goldman Sachs Annual Global Healthcare Conference
- Presentation date
- June 9
- Scheduled conference presentation date
- Presentation time
- 11:20 a.m. ET
- Scheduled start time of presentation
- Webcast archive period
- 30 days
- Minimum period replay will be available
Historical Context
-
Jefferies 2026 healthcare conference presentation announcement with webcast details.
-
Q1 2026 revenue and Galleri growth update plus regulatory milestones.
-
BofA 2026 health care conference presentation and webcast information.
-
Announcement of upcoming Q1 2026 results release and webcast timing.
-
Plan to present late-breaking NHS-Galleri and PATHFINDER 2 data at ASCO 2026.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Key Terms
nasdaq financial
AI-generated analysis. How Rhea-AI works. Not financial advice.
Live and replay webcasts may be accessed in the investor relations section of GRAIL's website at investors.grail.com. The webcast will be archived and available for reply for at least 30 days after the event.
About GRAIL
GRAIL is a healthcare company whose mission is to detect cancer early, when it can be cured. GRAIL is focused on alleviating the global burden of cancer by using the power of next-generation sequencing, population-scale clinical studies, and state-of-the-art machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. GRAIL's targeted methylation-based platform can support the continuum of care for screening and precision oncology, including multi-cancer early detection in symptomatic patients, risk stratification, minimal residual disease detection, biomarker subtyping, treatment and recurrence monitoring. GRAIL is headquartered in
For more information, visit grail.com.
View original content to download multimedia:https://www.prnewswire.com/news-releases/grail-to-present-at-the-goldman-sachs-47th-annual-global-healthcare-conference-302782179.html
SOURCE GRAIL, Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.